These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32027820)

  • 1. The Plasma Membrane as a Competitive Inhibitor and Positive Allosteric Modulator of KRas4B Signaling.
    Neale C; García AE
    Biophys J; 2020 Mar; 118(5):1129-1141. PubMed ID: 32027820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
    Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIP2 Influences the Conformational Dynamics of Membrane-Bound KRAS4b.
    McLean MA; Stephen AG; Sligar SG
    Biochemistry; 2019 Aug; 58(33):3537-3545. PubMed ID: 31339036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric KRas4B Can Modulate SOS1 Fast and Slow Ras Activation Cycles.
    Liao TJ; Jang H; Fushman D; Nussinov R
    Biophys J; 2018 Aug; 115(4):629-641. PubMed ID: 30097175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane Composition and Raf[CRD]-Membrane Attachment Are Driving Forces for K-Ras4B Dimer Stability.
    Andreadelis I; Kiriakidi S; Lamprakis C; Theodoropoulou A; Doerr S; Chatzigoulas A; Manchester J; Velez-Vega C; Duca JS; Cournia Z
    J Phys Chem B; 2022 Feb; 126(7):1504-1519. PubMed ID: 35142524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine 170 is an Environmentally Sensitive Membrane Anchor in the Disordered HVR of K-Ras4B.
    Neale C; García AE
    J Phys Chem B; 2018 Nov; 122(44):10086-10096. PubMed ID: 30351122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic K-Ras Binds to an Anionic Membrane in Two Distinct Orientations: A Molecular Dynamics Analysis.
    Prakash P; Zhou Y; Liang H; Hancock JF; Gorfe AA
    Biophys J; 2016 Mar; 110(5):1125-38. PubMed ID: 26958889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-bound KRAS approximates an entropic ensemble of configurations.
    Heinrich F; Van QN; Jean-Francois F; Stephen AG; Lösche M
    Biophys J; 2021 Sep; 120(18):4055-4066. PubMed ID: 34384763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GTP-Bound N-Ras Conformational States and Substates Are Modulated by Membrane and Point Mutation.
    Farcas A; Janosi L
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved allosteric perturbation of the GTPase domains by region 1 of Ras hypervariable regions.
    Gu X; Zhang Y; Long D
    Biophys J; 2024 Apr; 123(7):839-846. PubMed ID: 38419331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function.
    Cao S; Chung S; Kim S; Li Z; Manor D; Buck M
    J Biol Chem; 2019 Apr; 294(17):7068-7084. PubMed ID: 30792310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Modulators of K-Ras-Membrane Interactions.
    Morstein J; Shrestha R; Van QN; López CA; Arora N; Tonelli M; Liang H; Chen D; Zhou Y; Hancock JF; Stephen AG; Turbyville TJ; Shokat KM
    ACS Chem Biol; 2023 Sep; 18(9):2082-2093. PubMed ID: 37579045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDEδ.
    Ozdemir ES; Jang H; Gursoy A; Keskin O; Nussinov R
    J Phys Chem B; 2018 Aug; 122(30):7503-7513. PubMed ID: 29961325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane interactions of the globular domain and the hypervariable region of KRAS4b define its unique diffusion behavior.
    Goswami D; Chen D; Yang Y; Gudla PR; Columbus J; Worthy K; Rigby M; Wheeler M; Mukhopadhyay S; Powell K; Burgan W; Wall V; Esposito D; Simanshu DK; Lightstone FC; Nissley DV; McCormick F; Turbyville T
    Elife; 2020 Jan; 9():. PubMed ID: 31958057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B.
    Li X; Dai J; Ni D; He X; Zhang H; Zhang J; Fu Q; Liu Y; Lu S
    Int J Biol Macromol; 2020 Feb; 144():643-655. PubMed ID: 31816384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the Conformational and Energy Landscapes of KRAS Membrane Orientation.
    Prakash P; Gorfe AA
    J Phys Chem B; 2019 Oct; 123(41):8644-8652. PubMed ID: 31554397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Anionic Lipids Affect Spatiotemporal Properties of KRAS4B on Model Membranes.
    Ngo VA; Sarkar S; Neale C; Garcia AE
    J Phys Chem B; 2020 Jul; 124(26):5434-5453. PubMed ID: 32438809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Design of Myristoylated Cell-Penetrating Peptides Targeting Oncogenic K-Ras.G12D at the Effector-Binding Membrane Interface.
    Li Z; Buck M
    J Chem Inf Model; 2020 Jan; 60(1):306-315. PubMed ID: 31855604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-Sorting Specificity Encoded in K-Ras Membrane Anchor Regulates Signal Output.
    Zhou Y; Prakash P; Liang H; Cho KJ; Gorfe AA; Hancock JF
    Cell; 2017 Jan; 168(1-2):239-251.e16. PubMed ID: 28041850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant?
    Nussinov R; Tsai CJ; Jang H
    Semin Cancer Biol; 2019 Feb; 54():114-120. PubMed ID: 29307569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.